43 reports

Global Biomarker Partnering 2010-2015: Deal trends, players, financials and forecasts

1757 pages • By Currentpartnering

SummaryGlobal Biomarker Partnering 2010-2015: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.DescriptionThe Global Biomarker Partnering...

2 396 2 995 1 917
May 2015

Growth Drivers for Biomarkers in Healthcare : Managing Success in the Biomarker Industry - Challenges and Opportunities

73 pages • By Frost & Sullivan

Key Findings•The global biomarkers market was estimated at $ x billion in 2014 and is expected to reach $ x billion in 2020, growing at a robust CAGR of x % (2014–2020).•North America is the highest revenue-generating region with $ x billion revenue in 2014, accounting for x % of the total global biomarkers market.•Genomics...

2 800 3 500 2 240
Mar 2015

Biomarker - 30 European Companies Profiles

141 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

1 000 1 250 800
Mar 2015

Biomarker - European Panorama

434 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

2 500 3 125 2 000
Mar 2015

Biomarker - 50 European Experts & R&D Centers Profiles

251 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

1 200 1 500 960
Mar 2015

Biomarker - 30 Eastern Asian Companies Profiles

141 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

1 000 1 250 800
Mar 2015

Biomarker - 50 North American Experts & R&D Centers Profiles

251 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

1 200 1 500 960
Mar 2015

Biomarker - 30 Global Companies Profiles

141 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

1 000 1 250 800
Mar 2015

Biomarker - 50 Eastern Asian Experts & R&D Centers Profiles

251 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

1 200 1 500 960
Mar 2015

Biomarker - World Panorama

560 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

3 000 3 750 2 400
Mar 2015

Biomarker - Asian Panorama

433 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

2 500 3 125 2 000
Mar 2015

Biomarker - 50 Global Experts R&D Centers Profiles

251 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

1 200 1 500 960
Mar 2015

Biomarker - North American Panorama

433 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

2 500 3 125 2 000
Mar 2015

Biomarker - 30 North American Companies Profiles

141 pages • By Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not.An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule...

1 000 1 250 800
Mar 2015

BioMarker Strategies, LLC - Medical Equipment - Deals and Alliances Profile

17 pages • By Global Data

SummaryBioMarker Strategies, LLC (BioMarker Strategies) is a tissue-based cancer diagnostics company. The company offers SnapPath biomarker testing system. Its SnapPath biomarker testing system is an automated live tumor cell processing platform that enables next generation predictive tests - known as PathMap profiles - to guide...

200 250 160
Feb 2015

Global Cancer Biomarkers Market 2015-2019

89 pages • By Infiniti Research Limited

About Cancer BiomarkersBiomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs....

2 000 2 500 1 600
Jan 2015

Renal Biomarkers: Technologies and Global Markets

90 pages • By BCC Research

REPORT HIGHLIGHTSThe in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014. The market is expected to reach $1.1 billion by 2019, a compound annual growth rate (CAGR) of 7% from 2014 to 2019.This report provides:A comprehensive analysis of renal biomarkers...

5 320 6 650 4 256
Jan 2015

Companion Diagnostics Partnering Terms & Agreements

455 pages • By Currentpartnering

The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter...

1 596 1 995 1 277
Nov 2014

Biomarker Partnering Terms and Agreements

1048 pages • By Currentpartnering

The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering dealsBiomarker partnering agreement structureBiomarker partnering contract...

2 396 2 995 1 917
Nov 2014

Personalized Medicine Partnering Terms and Agreements

1289 pages • By Currentpartnering

Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The Personalized Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine partnering...

2 636 3 295 2 109
Nov 2014

Biomarkers in Amyotrophic Lateral Sclerosis

By CHI Insight Pharma Reports

OverviewBiomarkers in Amyotrophic Lateral Sclerosis is focused on the biomarker identification and development in patients with Amyotrophic Lateral Sclerosis (ALS). As a spin-off of Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the ALS space featured in...

559 699 447
Aug 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

741 pages • By Currentpartnering

The Personalized Medicine in Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies...

2 396 2 995 1 917
Aug 2014

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders - Overview

179 pages • By CHI Insight Pharma Reports

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders has a focus in biomarkers for neurodegenerative diseases and diagnostic applications in development. Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders. Although there...

1 996 2 495 1 597
Jul 2014

Biomarkers in Alzheimers Disease

95 pages • By CHI Insight Pharma Reports

OverviewBiomarkers in Alzheimer’s Disease is focused on the biomarker identification and development in patients with Alzheimer’s Disease. As a spin-off of Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the Alzheimer’s Disease space featured in the parent report,...

559 699 447
Jul 2014

Analysis of the Western European Biomarkers Market in Drug Discovery and Development

153 pages • By Frost & Sullivan

Increasing Applications of Biomarkers are Driving GrowthBiomarkers will certainly change the way healthcare is provided. They are being increasingly used in early drug development and for clinical use as well, boosting their demand. The penetration of biomarkers in various therapeutic applications, the impact of market trends...

4 800 6 000 3 840
Jun 2014

Companion Diagnostics Market (2nd Edition), 2014-2024

233 pages • By Roots Analysis Private Ltd.

INTRODUCTIONWith an influx of new technologies and increasing awareness about personalized medicine, the pharmaceutical industry has steadily started to adopt a more customized drug development model. The concept of companion diagnostics holds huge potential for pharma companies as well as medical community. This new approach...

1 519 1 899 1 215
Jun 2014

Companion Diagnostics in Personalized Medicine and Cancer Therapy

292 pages • By TriMark Publications

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic application and clinical outcome of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays...

2 720 3 400 2 176
Jun 2014

GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)

232 pages • By Kelly Scientific Publications

“GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline Analysis)” by Kelly Scientific Publications is a comprehensive report on the cancer biomarker industry and its impact on the health system....

2 800 3 500 2 240
May 2014

Biomarkers: Technologies and Global Markets

169 pages • By BCC Research

REPORT HIGHLIGHTSThe global biomarkers market is expected to grow from $29.3 billion in 2013 to $53.6 billion in 2018, a compound annual growth rate (CAGR) of 12.8%.This report provides:An overview of the global market for biomarkers.Analyses of global market trends, with data from 2012 and 2013, and...

5 320 6 650 4 256
Apr 2014

Mass Spectrometry for Clinical Applications: Market Analysis and End User Survey

250 pages • By Kalorama Information

For capacity, accuracy, and specificity of analysis, the use of mass spectrometry in clinical diagnostics and clinical research has grown dramatically in recent years. This Kalorama Information report, Mass Spectrometry for Clinical Applications: Market Analysis and End User Survey, looks at the growth of Mass Spec systems being used in diagnostics...

3 520 4 400 2 816
Apr 2014